| Start on Biologic (%) | Start on Oral MTX (%) | Oral MTX for Duration of Follow-up (%)* | Switch to or Add Biologic to Oral MTX (%)* | Switch from Oral to SC MTX (%)* | |
|---|---|---|---|---|---|
| 2009 (N=48,910) | 13,270 (27.1%) | 35,640 (72.9%) | 21,850 (61.3%) | 12,554 (35.2%) | 1,236 (3.5%) |
| MTX dose at 90 days** | – | – | – | 15.3 | 16.1 |
| 2012 (N=107,636) | 38,309 (35.6%) | 69,327 (64.4%) | 50,338 (72.6%) | 15,013 (21.6%) | 3,976 (7.8%) |
| MTX dose at 90 days** | – | – | – | 15.9 | 16.7 |
*Percent started on oral MTX, **mg/week.